MedTrace Logo

Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors

NCT03372720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2022-04-22

No results posted yet for this study

Summary

This randomized pilot trial studies how well fractional carbon dioxide (CO2) laser therapy works in minimizing genitourinary syndrome of menopause (GSM) in gynecological cancer survivors. Fractional CO2 laser therapy may reduce symptoms of GSM in survivors of gynecologic cancers.

Conditions

  • Cervical Carcinoma
  • Dyspareunia
  • Endometrial Carcinoma
  • Ovarian Carcinoma
  • Vaginal Carcinoma
  • Vaginal Dryness
  • Vulvar Carcinoma

Interventions

PROCEDURE

Laser Therapy

Undergo fractional CO2 laser therapy

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Sham Intervention

Undergo sham laser therapy

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Allison Quick, MD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-11
Primary Completion
2019-12-18
Completion
2022-04-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03372720 on ClinicalTrials.gov